Alignment Healthcare, Inc. (NASDAQ:ALHC – Get Free Report) insider Christopher J. Joyce sold 16,000 shares of Alignment Healthcare stock in a transaction dated Friday, June 14th. The shares were sold at an average price of $8.01, for a total transaction of $128,160.00. Following the transaction, the insider now owns 422,912 shares of the company’s stock, valued at $3,387,525.12. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.
Alignment Healthcare Stock Performance
Shares of ALHC stock opened at $7.90 on Tuesday. The firm has a market cap of $1.51 billion, a price-to-earnings ratio of -9.40 and a beta of 1.43. The company has a debt-to-equity ratio of 1.23, a quick ratio of 1.57 and a current ratio of 1.57. Alignment Healthcare, Inc. has a 52 week low of $4.46 and a 52 week high of $9.20. The firm’s 50-day simple moving average is $6.60 and its two-hundred day simple moving average is $6.69.
Alignment Healthcare (NASDAQ:ALHC – Get Free Report) last announced its quarterly earnings data on Thursday, May 2nd. The company reported ($0.25) EPS for the quarter, missing the consensus estimate of ($0.24) by ($0.01). Alignment Healthcare had a negative return on equity of 91.06% and a negative net margin of 7.81%. The company had revenue of $628.60 million during the quarter, compared to the consensus estimate of $599.75 million. During the same period in the prior year, the firm posted ($0.20) EPS. The business’s revenue was up 43.1% on a year-over-year basis. As a group, equities analysts forecast that Alignment Healthcare, Inc. will post -0.67 earnings per share for the current year.
Institutional Trading of Alignment Healthcare
Wall Street Analyst Weigh In
Several research analysts recently weighed in on ALHC shares. Bank of America upgraded shares of Alignment Healthcare from a “neutral” rating to a “buy” rating and boosted their price target for the stock from $7.75 to $11.00 in a report on Thursday, May 30th. Stifel Nicolaus cut their price target on shares of Alignment Healthcare from $11.00 to $9.00 and set a “buy” rating on the stock in a report on Tuesday, April 23rd. Barclays started coverage on shares of Alignment Healthcare in a report on Wednesday, March 6th. They set an “underweight” rating and a $4.50 price target on the stock. UBS Group cut their price target on shares of Alignment Healthcare from $9.00 to $8.50 and set a “neutral” rating on the stock in a report on Wednesday, February 28th. Finally, William Blair restated an “outperform” rating on shares of Alignment Healthcare in a report on Wednesday, March 6th. One analyst has rated the stock with a sell rating, two have assigned a hold rating, six have given a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $9.20.
Read Our Latest Stock Analysis on Alignment Healthcare
About Alignment Healthcare
Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.
Featured Articles
- Five stocks we like better than Alignment Healthcare
- P/E Ratio Calculation: How to Assess Stocks
- Buffett Bails on BYD: What It Means for the Future of EV Stocks
- Top Biotech Stocks: Exploring Innovation Opportunities
- Domino’s vs. Papa John’s: Stock Showdown of Pizza Giants
- What Are Dividends? Buy the Best Dividend Stocks
- Williams-Sonoma Makes Stock More Accessible with a Stock Split
Receive News & Ratings for Alignment Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alignment Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.